MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancerShunsuke Kitajima, David A. Barbie, Benjamin F. Springer et al.|Cancer Cell|2022Cited by 101
An integrative pharmacogenomics analysis identifies therapeutic targets in KRAS-mutant lung cancerHaiyun Wang, Jens Köhler|EBioMedicine|2019Cited by 31